An April 9 San Francisco Chronicle story, “Brain scan could detect Alzheimer’s in earliest stages,” featured work by William Jagust, senior faculty in the Molecular Biophysics & Integrated Bioimaging Division. The story was based on a campus news release written by the Lab’s Public Affairs’ Sarah Yang.

Scientists have developed an imaging process that for the first time, they say, can identify and track the progression of Alzheimer’s disease in people’s brains, even when there are no symptoms — a development that could lead to earlier diagnosis and treatment for a disease that has become more pervasive among the growing number of older Americans. “These scans have revolutionized the ways we think about Alzheimer’s disease,” Jagust said. “It’s opened up whole new way of doing research.” Read the full story.

New research shows for the first time that PET scans can track the progressive stages of Alzheimer’s disease in cognitively normal adults, a key advance in the early diagnosis and staging of the neurodegenerative disorder. William Jagust, senior faculty scientist in the Molecular Biophysics & Integrated Bioimaging Division, is the study’s principal investigator. A video abstract of the findings, published March 2 in the journal Neuron, can be found here. Read more at UC Berkeley News.